RJFSA
RCEL icon

Raymond James Financial Services Advisors’s Avita Medical RCEL Stock Holding History

Raymond James Financial Services Advisors’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,751
Closed -$147K – 2887
2020
Q1 		$147K Buy
+4,751
New +$197K ﹤0.01% 2160

Other funds holding RCEL

BC
Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.8B AUM 19.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
FC
Financial Consulate Hunt Valley, Maryland $899M AUM 20.23% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Raymond James Financial Services Advisors's RCEL Position: Q2 2020 in Review

Raymond James Financial Services Advisors sold out of Avita Medical (RCEL) in Q2 2020, closing a stake of 4,751 shares — an estimated $147K sold.

Raymond James Financial Services Advisors first reported a position in RCEL in Q1 2020 and held it in 1 quarter. The position peaked at $147K in Q1 2020. 34 funds tracked by Wall St. Rank hold RCEL as of Q2 2020.

  • Raymond James Financial Services Advisors reported no remaining Avita Medical position as of Q2 2020 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 4,751 Avita Medical shares in Q2 2020, an estimated $147K.
  • Raymond James Financial Services Advisors first reported a position in Avita Medical in Q1 2020 and held it in 1 quarter.
  • Raymond James Financial Services Advisors's Avita Medical position peaked at $147K in Q1 2020.
  • 34 funds tracked by Wall St. Rank held Avita Medical as of Q2 2020.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2020, filed 17 Jul 2020.